India to Philippines: Capecitabine Export Trade Route
India has recorded 160 verified shipments of Capecitabine exported to Philippines, representing a combined trade value of $2.1M USD. This corridor is served by 17 active Indian exporters, with an average shipment value of $13.4K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 25% of total export value with 6 shipments worth $541.8K USD. On the buying side, Ve Pharma Inc. is the largest importer in Philippines with $346.0K USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, VEXXA LIFESCIENCES PVT. LTD. , INTAS PHARMACEUTICALS LIMITED — together control 53% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Philippines Capecitabine corridor is one of India's established pharmaceutical export routes, with 160 shipments documented worth a combined $2.1M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 25% of all export value, reflecting the consolidated nature of India's capecitabine manufacturing sector.
Across 17 active suppliers, the average shipment value stands at $13.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with capecitabine's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 24.6%, placing it at rank #17 among India's top capecitabine export destinations globally.
On the import side, key buyers of Indian capecitabine in Philippines include Ve Pharma Inc. , SUN PHARMA PHILIPPINES INC., VE PHARMA INC and 17 others. Ve Pharma Inc. is the single largest importer with 62 shipments valued at $346.0K USD.
Route Characteristics
- Average transit29 days
- Peak seasonQ2
- Primary modeSea freight
- Top portDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#17
- Annual growth+24.6%
- Demand growth+22.6%
- Regulatory ease74/100
Top 10 Indian Capecitabine Exporters to Philippines
Showing top 10 of 17 Indian suppliers exporting Capecitabine to Philippines, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $90.3K per shipment | 6 | $541.8K | 25.3% |
| 2 | VEXXA LIFESCIENCES PVT. LTD. Avg $5.6K per shipment | 62 | $346.0K | 16.2% |
| 3 | INTAS PHARMACEUTICALS LIMITED Avg $81.3K per shipment | 3 | $244.0K | 11.4% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $77.1K per shipment | 3 | $231.4K | 10.8% |
| 5 | VEXXA LIFESCIENCES PVT. LTD. Avg $7.0K per shipment | 28 | $195.6K | 9.1% |
| 6 | VEXXA LIFESCIENCES PRIVATE LIMITED Avg $5.1K per shipment | 34 | $174.8K | 8.2% |
| 7 | NAPROD LIFE SCIENCES PRIVATE LIMITED Avg $98.4K per shipment | 1 | $98.4K | 4.6% |
| 8 | NAPROD LIFE SCIENCES PRIVATE LIMITED Avg $83.1K per shipment | 1 | $83.1K | 3.9% |
| 9 | BETA DRUGS LIMITED Avg $7.5K per shipment | 10 | $75.5K | 3.5% |
| 10 | BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED Avg $29.5K per shipment | 1 | $29.5K | 1.4% |
This table shows the top 10 of 17 Indian companies exporting capecitabine to Philippines, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED, VEXXA LIFESCIENCES PVT. LTD. , INTAS PHARMACEUTICALS LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , VEXXA LIFESCIENCES PVT. LTD., VEXXA LIFESCIENCES PRIVATE LIMITED, NAPROD LIFE SCIENCES PRIVATE LIMITED , NAPROD LIFE SCIENCES PRIVATE LIMITED, BETA DRUGS LIMITED, BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED . SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 6 shipments worth $541.8K USD, giving it a 25% market share. The top 3 suppliers together account for 53% of the total trade value on this route.
Showing top 10 of 17 total Indian exporters on the India to Philippines Capecitabine export route.
Top 10 Capecitabine Importers in Philippines
Showing top 10 of 20 known buyers in Philippines receiving Capecitabine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian capecitabine in Philippines include Ve Pharma Inc. , SUN PHARMA PHILIPPINES INC., VE PHARMA INC, SUN PHARMA PHILIPPINES INC, SUN PHARMA PHILIPPINES INC. , among 20 total buyers. The largest importer is Ve Pharma Inc. , accounting for $346.0K USD across 62 shipments — representing 16% of all capecitabine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | Ve Pharma Inc. | 62 | $346.0K | 16.2% |
| 2 | SUN PHARMA PHILIPPINES INC. | 3 | $302.6K | 14.2% |
| 3 | VE PHARMA INC | 45 | $289.5K | 13.5% |
| 4 | SUN PHARMA PHILIPPINES INC | 3 | $239.2K | 11.2% |
| 5 | SUN PHARMA PHILIPPINES INC. | 3 | $231.4K | 10.8% |
| 6 | TO THE ORDER | 2 | $160.7K | 7.5% |
| 7 | MULTICARE PHARMACEUTICALS PHILIPPIN | 1 | $98.4K | 4.6% |
| 8 | Ve Pharma Inc | 16 | $85.7K | 4.0% |
| 9 | UNILAB, INC. | 1 | $83.2K | 3.9% |
| 10 | MULTICARE PHARMACEUTICALS PHILIPPIN | 1 | $83.1K | 3.9% |
Showing top 10 of 20 Capecitabine importers in Philippines on this route.
Top 10 Capecitabine Formulations Imported by Philippines
Showing top 10 of 64 product formulations shipped on the India to Philippines Capecitabine route, ranked by trade value
Philippines imports a wide range of capecitabine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — CAXETA 500 TABLETS (CAPECITABINE TABLETS — accounts for $409.6K USD across 4 shipments. There are 64 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CAXETA 500 TABLETS (CAPECITABINE TABLETS | 4 | $409.6K | 19.2% |
| 2 | CAPVEX 500 (CAPECITABINE TABLETS USP 500 | 22 | $122.1K | 5.7% |
| 3 | CAXETA 500 TABLETS CAPECITABINE TABLETS500 MG ACT QTY 2326 PACKX10X10S | 1 | $119.9K | 5.6% |
| 4 | Capvex 500 (CAPECITABINE TABLETS USP 500 | 22 | $118.1K | 5.5% |
| 5 | Capvex 500 Tabs (CAPECITABINE TABLETS US | 17 | $104.3K | 4.9% |
| 6 | NAPROCAP 500 (CAPECITABINE TABLETS USP 5 | 1 | $98.4K | 4.6% |
| 7 | PHARM DRUG&MED CELABIN CAPECITA 500MG 6X10T PP (UNI-PHI)EACH FILM COATED TABLETCONTAINS: CAPECITABINE USP 500 MG | 1 | $83.2K | 3.9% |
| 8 | NAPROCAP 500 (CAPECITABINE TABLETS USP 500MG) (12000 PACKX10=120000 TABS)NOS | 1 | $83.1K | 3.9% |
| 9 | PHARM DRUG MED CELABIN CAPECITA 500MG 6X10T PP UNI PHI EACH FILM COATED TABLETCONTAINS CAPECITABINE USP 500 MG | 1 | $80.7K | 3.8% |
| 10 | PHARMA DRUGS AND MEDICINE CELABIN CAPECITA 500MG 6X10T PP UNI PHI ECH FLM CTD TAB CONT CAPECITABINE USP 500MG ASPERINV | 1 | $80.0K | 3.7% |
Showing top 10 of 64 Capecitabine formulations imported by Philippines on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 72%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 93 shipments. Transit time averages 29 days by sea.
Market Dynamics
India's capecitabine exports to Philippines are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 17 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, VEXXA LIFESCIENCES PVT. LTD. , INTAS PHARMACEUTICALS LIMITED — together account for 53% of total trade value on this route. The average shipment value of $13.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as capvex 500 (capecitabine tablets usp 500 and caxeta 500 tablets capecitabine tablets500 mg act qty 2326 packx10x10s, suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, Ve Pharma Inc. is the largest importer with 62 shipments worth $346.0K USD — representing 16% of all capecitabine imports from India on this route. A total of 20 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $2.1M
- Avg. Shipment
- $13.4K
- Suppliers
- 17
- Buyers
- 20
- Transit (Sea)
- ~29 days
- Annual Growth
- +24.6%
Related Analysis
Other Capecitabine Routes
Unlock the Full India to Philippines Capecitabine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 160 shipments on this route.
Frequently Asked Questions — India to Philippines Capecitabine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Capecitabine to Philippines?
The leading Indian exporters of Capecitabine to Philippines are SUN PHARMACEUTICAL INDUSTRIES LIMITED, VEXXA LIFESCIENCES PVT. LTD. , INTAS PHARMACEUTICALS LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 25% of total trade value on this route.
Q What is the total value of Capecitabine exports from India to Philippines?
India exports Capecitabine to Philippines worth approximately $2.1M USD across 160 recorded shipments. The average value per shipment is $13.4K USD.
Q Which ports does India use to ship Capecitabine to Philippines?
The most active port of origin is DELHI AIR CARGO ACC (INDEL4) with 93 shipments. Indian exporters primarily use sea freight for this route, with 72% of shipments going by sea and 20% by air.
Q How long does shipping take from India to Philippines for Capecitabine?
The average transit time for Capecitabine shipments from India to Philippines is approximately 29 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Philippines Capecitabine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 24.6% with demand growth tracking at 22.6%. The route is ranked #17 among India's top Capecitabine export destinations globally.
Q How many suppliers are active on the India to Philippines Capecitabine route?
There are currently 17 active Indian suppliers exporting Capecitabine to Philippines. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 25% of total shipment value.
Q Who are the main importers of Capecitabine from India in Philippines?
The leading importers of Indian Capecitabine in Philippines include Ve Pharma Inc. , SUN PHARMA PHILIPPINES INC., VE PHARMA INC, SUN PHARMA PHILIPPINES INC, SUN PHARMA PHILIPPINES INC. . Ve Pharma Inc. is the largest buyer with 62 shipments worth $346.0K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Philippines export trade corridor identified from Indian Customs (DGFT) records for Capecitabine.
- 2.Supplier/Buyer Matching: 17 Indian exporters and 20 importers in Philippines matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 160 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
160 Verified Shipments
17 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists